CCL18 and idiopathic pulmonary fibrosis: Regarding the innate immune system, Prasse et al. [46] found that serum concentration of CC chemokine ligand-18 (CCL18) was associated with severity and mortality in IPF patients and it was used as the first biomarker to predict IPF mortality.